Prevention and Treatment of Atherosclerosis: Improving State-of-the-Art Management and Search for Novel Targets: Handbook of Experimental Pharmacology, cartea 270
Editat de Arnold von Eckardstein, Christoph J. Binderen Limba Engleză Paperback – feb 2022
Toate formatele și edițiile | Preț | Express |
---|---|---|
Paperback (1) | 305.47 lei 39-44 zile | |
Springer International Publishing – feb 2022 | 305.47 lei 39-44 zile | |
Hardback (1) | 393.44 lei 39-44 zile | |
Springer International Publishing – feb 2022 | 393.44 lei 39-44 zile |
Din seria Handbook of Experimental Pharmacology
- 5% Preț: 1425.04 lei
- 5% Preț: 907.42 lei
- 5% Preț: 3446.28 lei
- 5% Preț: 730.30 lei
- 5% Preț: 1397.04 lei
- 5% Preț: 1406.17 lei
- 5% Preț: 1401.51 lei
- 5% Preț: 1891.48 lei
- 5% Preț: 1883.44 lei
- 5% Preț: 1898.12 lei
- 5% Preț: 2074.57 lei
- 5% Preț: 2076.90 lei
- 5% Preț: 2074.36 lei
- 5% Preț: 1088.15 lei
- 5% Preț: 1076.01 lei
- 5% Preț: 1391.47 lei
- 5% Preț: 1082.46 lei
- 5% Preț: 1082.46 lei
- 5% Preț: 1085.70 lei
- 5% Preț: 1084.27 lei
- 5% Preț: 1083.37 lei
- 5% Preț: 1150.54 lei
- 5% Preț: 400.28 lei
- 5% Preț: 401.38 lei
- 5% Preț: 539.89 lei
- 5% Preț: 705.92 lei
- 5% Preț: 718.27 lei
- 5% Preț: 716.49 lei
- 5% Preț: 731.34 lei
- 5% Preț: 732.60 lei
- 5% Preț: 710.56 lei
- 5% Preț: 727.78 lei
- 5% Preț: 385.33 lei
- 5% Preț: 720.79 lei
- 5% Preț: 713.60 lei
- 5% Preț: 381.69 lei
- 5% Preț: 715.93 lei
- 5% Preț: 725.61 lei
- 5% Preț: 715.42 lei
- 5% Preț: 708.78 lei
- 5% Preț: 716.49 lei
- 5% Preț: 711.98 lei
- 5% Preț: 3445.03 lei
- 5% Preț: 714.51 lei
- 5% Preț: 722.21 lei
- 5% Preț: 716.13 lei
- 5% Preț: 723.83 lei
- 5% Preț: 891.51 lei
- 5% Preț: 705.54 lei
Preț: 305.47 lei
Preț vechi: 321.54 lei
-5% Nou
Puncte Express: 458
Preț estimativ în valută:
58.47€ • 61.38$ • 48.30£
58.47€ • 61.38$ • 48.30£
Carte tipărită la comandă
Livrare economică 27 ianuarie-01 februarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9783030860783
ISBN-10: 3030860787
Pagini: 538
Ilustrații: X, 538 p. 40 illus., 37 illus. in color.
Dimensiuni: 155 x 235 mm
Ediția:1st ed. 2022
Editura: Springer International Publishing
Colecția Springer
Seria Handbook of Experimental Pharmacology
Locul publicării:Cham, Switzerland
ISBN-10: 3030860787
Pagini: 538
Ilustrații: X, 538 p. 40 illus., 37 illus. in color.
Dimensiuni: 155 x 235 mm
Ediția:1st ed. 2022
Editura: Springer International Publishing
Colecția Springer
Seria Handbook of Experimental Pharmacology
Locul publicării:Cham, Switzerland
Cuprins
Diet, Life Style, Smoking.- Blood Pressure Lowering.- Glycemic Control in Diabetes.- LDL-Cholesterol Lowering.- Antithrombotic Therapy (Platelet Inhibition, Anti-coagulation).- Triglyceride Rich Lipoproteins.- HDL.- Lipoprotein(a).- Obesity, Non-alcoholic Fatty Liver Disease, and Metabolic Syndrome.- Nutraceuticals / Functional Food.- Adipose Tissue (WAT, BAT).- Microbiota and Cardiometabolic Disease.- SMCs, Matrix.- Immune Modulation.- NETs and Neutrophils.- Genomic Strategies Towards Identification of Novel Therapeutic Targets.- Non Coding RNAs.- Metabolomics, Lipidomics.- Epigenomics.
Notă biografică
Previous publications in the Handbook of Experimental Pharmacology series co-edited by Prof. Arnold von Eckardstein : Atherosclerosis: Diet and Drugs, 2005, Arnold von Eckardstein; High Density Lipoproteins, 2015, Arnold von Eckardstein, Dimitris Kardassis (eds.), Open Access
Textul de pe ultima copertă
This open access book is supported by the European Atherosclerosis Society Association (EAS). This follow-up edition of the well-received Handbook volume 'Atherosclerosis: Diet and Drugs' reflects the state-of-the-art and most recent developments in atherosclerosis research. Outstanding international experts give a comprehensive overview of the field covering topics, such as improving the treatment focusing on established targets, novel drug developments addressing pre-defined targets, hypothesis-based and hypothesis-free approaches to unravel novel targets.
Caracteristici
Summarizes the latest studies on the management of cardiovascular risk factors Reviews exhaustively the key recent research into the pathogenesis of atherosclerotic cardiovascular diseases Outlines various strategies of identifying and validating novel targets for prevention and treatment of atherosclerosis This book is open access, which means that you have free and unlimited access